2014
DOI: 10.1007/s00104-013-2685-7
|View full text |Cite
|
Sign up to set email alerts
|

Chirurgische Therapie von Lungenmetastasen

Abstract: Surgical treatment of lung metastases from extrathoracic malignancies is an established procedure. Pulmonary metastases are common. Generally, lung metastases are located peripherally and are asymptomatic. Involvement of the bronchial system or infiltration of the chest wall can be symptomatic. The indications for resection are an interdisciplinary decision. Metastasectomy can be with curative or palliative intent. Prerequisitess for pulmonary metastasectomy are primary tumor under control, the absence of extr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
2
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 25 publications
1
2
0
Order By: Relevance
“…As the number of pulmonary metastases increases, the likelihood of incomplete resection, the burden of widespread occult disease in the lungs, and the probability of recurrence in the lung are higher. 23,24 Consistent with the literature, in this research, the number of nodules is between 1-2. 21 Outcomes are better with fewer metastases.…”
Section: Discussionsupporting
confidence: 87%
“…As the number of pulmonary metastases increases, the likelihood of incomplete resection, the burden of widespread occult disease in the lungs, and the probability of recurrence in the lung are higher. 23,24 Consistent with the literature, in this research, the number of nodules is between 1-2. 21 Outcomes are better with fewer metastases.…”
Section: Discussionsupporting
confidence: 87%
“…In 30 to 50% of all patients with extrathoracic tumors, lung metastases develop during the course of the disease. 1 If special conditions are fulfilled, the resection of lung metastases can improve long-term survival. [2][3][4] In recent years, the use of a diode pumped neodymiumdoped yttrium aluminium garnet (Nd:YAG) laser has become increasingly popular in surgical resections of lung metastases.…”
Section: Introductionmentioning
confidence: 99%
“…Although many tumors can metastasize to the bronchus, the most common extrathoracic malignancies associated with EBM are colorectal, breast, kidney, stomach, ovarian, thyroid, uterine, testicular, nasopharynx, prostate, and adrenal carcinomas and sarcomas. [ 4 5 6 ] The time between the diagnosis of the primary tumor and appearance of EBM is approximately 9 months–5 years. [ 7 8 9 ] Most of the times, it is difficult to diagnose EBM from primary bronchogenic carcinoma without the prior history of extrathoracic malignancy, because clinical, radiological, and bronchoscopic findings cannot differentiate these two entities.…”
Section: Introductionmentioning
confidence: 99%